Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice

British Journal of Radiology

Volumn 78, Issue 928, 2005, Pages 338-342

  Cornelissen, B ^a   Kersemans, V ^a   Jans, L ^b   Staelens, L ^a   Oltenfreiter, R ^a   Thonissen, T ^a   Achten, E ^b   Slegers, G ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

WATER;

ACCURACY; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISSECTION; IMAGING SYSTEM; INOCULATION; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; RELIABILITY; SUBCUTANEOUS TISSUE TUMOR; TUMOR NECROSIS; TUMOR VOLUME; VOLUMETRY;

ANIMALS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; NEOPLASMS;

EID: 17144383210     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/20260420     Document Type: Article

References (13)

1. Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 2002;223:91-7.
2. Gibbs P, Buckley DL, Blackband SJ, Horsman A. Tumour volume determination from MR images by morphological segmentation. Phys Med Biol 1996;41:2437-46.
3. Joe BN, Fukui MB, Meltzer CC, Huang Q-S, Day RS, Greer PJ, et al. Brain tumor volume measurement: comparison of manual and semiautomated methods. Radiology 1999;212: 811-6.
4. Kaus MR, Warfield SK, Nabavi A, Black PM, Jolsz FA, Kikinis R. Automated segmentation of MR images of brain tumors. Radiology 2001;218:586-91.
5. Lundin P, Engström BE, Karlsson FA, Burman P. Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR. Am J Neuroradiol 1997;18:765-72.
6. Mayr NA, Taoka T, Yuh WT, Denning LM, Zhen WK, Paulino AC, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002;52:14-22.
7. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999;281:1395-400.
8. End DW, Smets G, Todd AV, Applegate TL, Fuery CJ, Angibaud P, et al. Characterisation of the antitumour effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. Cancer Res 2001;6: 131-7.
9. Orlova A, Bruskin A, Sjöström A, Lundqvist H, Gedda L, Tolmachev V. Cellular processing of 125I- and 111 In-labelled epidermal growth factor (EGF) bound to cultured A431 tumor cells. Nucl Med Biol 2000;27:827-35.
10. Sundberg AL, Almqvist Y, Orlova A, Blomquist E, Jensen HJ, Gedda L, et al. Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF. Eur J Nucl Med Mol Imaging 2003;30:1348-56.
11. Van den Berg AP. Enkele kernpunten bij onderzoekskunst en bewerking van resultaten. Personal communication.
12. Waterton JC, Alott CP, Pickford R, Hamilton EA, Valcaccia B. Assessment of mouse tumour xenograft volumes in vivo by ultrasound imaging, MRI and calliper measurement. Proceedings of the 19th LH Gray Conference: Quantitative Imaging in Oncology 146-149; Eds Faulkner K, Carey B, Crellin A, Harisson RM. BIR, London 1997.
13. Hardy PA, Recht MP, Piraino D, Thomasson D. Optimization of a dual echo in the steady state (DESS) free-precession sequence for imaging cartilage. J Magn Reson Imaging 1996;6:329-35.